In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
Carrillo-Muñoz
A J
AJ
Quindós
G
G
Del Valle
O
O
Santos
P
P
Giusiano
G
G
Guardia
C
C
Eraso
E
E
Ezkurra
P A
PA
Tur-Tur
C
C
Hernández-Molina
J M
JM
D000935:Antifungal Agents / Q000494:pharmacology*; D003883:Arthrodermataceae / Q000187:drug effects / Q000302:isolation & purification; D000077768:Ciclopirox; D004305:Dose-Response Relationship, Drug; D015725:Fluconazole / Q000494:pharmacology; D005658:Fungi / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D009025:Morpholines / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology; D014009:Onychomycosis / Q000382:microbiology*; D011728:Pyridones / Q000494:pharmacology; D000077291:Terbinafine; D013876:Thiophenes / Q000494:pharmacology*; D015003:Yeasts / Q000187:drug effects / Q000302:isolation & purification
D000935:Antifungal Agents; D007093:Imidazoles; D009025:Morpholines; D009281:Naphthalenes; D011728:Pyridones; D013876:Thiophenes; D000077768:Ciclopirox; C061131:sertaconazole; D015725:Fluconazole; C038974:amorolfine; D000077291:Terbinafine; C036596:bifonazole